ResearchMoz

La Merie Publishing Market Research Reports

La Merie Publishing is an independent business information provider for the biopharmaceutical industry. We publish reports and newsletters, and provide the service of preparing tailor-made reports. The full range of our products are commercialized via our associated biotech portal PipelineReview.com and reselling partners.

List of reports from La Merie Publishing

Displaying 1 to 20 (of 20 records)
Pages: « Last  1   
Competitor Analysis: Coagulation Factors
May 2013  
Competitor Analysis: Coagulation Factors Product description The Competitive Intelligence Report Coagulation Factors provides a competitor analysis of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or acquired coagulation disorders as of May 2013. Purchase of the pdf report includes a 6-month online access to...
$784
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
May 2013  
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors The new Competitive Intelligence Report Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors of May 2013 provides a competitor analysis in the product portfolios and development pipelines of ten major classes of therapeutic proteins and their biosimilar and...
$2092
Competitor Analysis: Antibody-Drug Conjugates (ADC)
Apr 2013  
Product description The present Competitive Intelligence Report about Antibody-Drug Conjugates (ADC) / Immunoconjugates provides a competitor evaluation in the field of tumor targeting antibodies conjugated via a linker with a drug payload for treatment of cancer as of April 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and...
$785
Antibody Technologies and Attrition Rates - an industry analysis 2013
Mar 2013  
The report “Antibody Technologies and Attrition Rates – an industry analysis 2013” is based on the identification of the antibody generation technologies of 504 naked antibodies in clinical or market stages. Information was retrieved from scientific and corporate publications as well as from patent and legal literature. The report provides descriptive statistics of the...
$2781
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
Dec 2012  
Toll-Like Receptor (TLR) Agonists & Antagonists Product description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, RNA and vaccines targeting the toll-like receptors (TLR) for treatment or prevention of cancer, infectious diseases, sepsis and...
$910
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012
Mar 2012  
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 This report “ Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists - A Target Pipeline and Stakeholder Analysis 2012 ” published in March 2012 provides a compilation of business, commercial, clinical and scientific information about GLP-1 receptor agonists. A comprehensive...
$2524
Competitor Analysis: Anti-Infective Antibodies
Nov 2011  
Competitor Analysis: Anti-Infective Antibodies Product description The present Competitive Intelligence Report about Anti-Infective Antibodies provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies and human plasma-derived immunoglobulins and hyperimmunes for post-exposure prophylaxis and treatment of infectious diseases as of November 2011....
$1029
Competitor Analysis: Cancer Vaccines
Nov 2011  
Cancer Vaccines Product description The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic vaccines against cancer. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database...
$900
Coagulation Factors 2011. Who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis
Oct 2011  
Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis Product description The report Coagulation Factors 2011 who does meet the market needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis provides a description, evaluation and assessment of the recombinant coagulation factor R&D...
$3087
Vaccine Pipeline Database: 1-Year Subscription
Oct 2011  
Vaccine Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use...
$1287
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis
Sep 2011  
Antibody-Drug Conjugates 2011 - real breakthrough still to come. A Technology, Stakeholder and R&D Pipeline Analysis Product description This report “Antibody-Drug Conjugates 2011 – real breakthrough still to come: A Technology, Stakeholder and R&D Pipeline Analysis” published in September 2011 provides the most complete compilation of information about...
$2524
Competitor Analysis: Targeted Therapy of Hepatitis C
Aug 2011  
Targeted Therapy of Hepatitis C Product description The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates...
$772
RNA Therapeutics Pipeline Database: 1-Year Subscription
Mar 2011  
RNA Therapeutics Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary RNA Therapeutics Pipeline Database provides online access to RNA Therapeutics on the market and in research & development. RNA Therapeutics include the classes of antisense, aptamers, small interfering RNA (siRNA)/RNA interference (RNAi) or Locked Nucleic Acid (LNA)...
$772
Therapeutic Protein Pipeline Database: 1-Year Subscription
Feb 2011  
Therapeutic Protein Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Therapeutic Protein Pipeline Database provides online access to more than 1,700 project entries for therapeutic proteins on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D...
$1544
Antibody Pipeline Database: 1-Year Subscription
Nov 2010  
Antibody Pipeline Database: 1-Year Subscription Product description Subscription to La Meries proprietary Antibody Pipeline Database provides online access to more than 1,600 project entries for therapeutic antibodies on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D...
$1544
R&D Drug Pipeline Database: 2-Months Subscription
Aug 2010  
R&D Drug Pipeline Database: 2-Months Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the...
$2573
R&D Drug Pipeline Database: 1-Year Subscription
Aug 2010  
R&D Drug Pipeline Database: 1-Year Subscription Product description Subscription to La Meries proprietary R&D Drug Pipeline Database provides online access to more than 12,000 project entries in all therapeutic areas and product categories. Each project is specified for its Target or Mechanism of Action, Product Category, Therapeutic Area, indication and R&D Phase. Use of the...
$7719
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access
Jun 2010  
Flat-Rate Subscription to La Merie Reports with 24/7 Online Access Subscription to this product provides online access during one year to all reports published by La Merie and available in the online store during the subscription. Among La Merie reports are more than 100 Competitor Analysis reports as well as a growing number of Brief and Full Reports. La Merie reports are continuously...
$5146
Oncology Pipeline Database: 1-Year Subscription
May 2010  
Oncology Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest...
$2316
Oncology Pipeline Database: 6-Month Subscription
Feb 2010  
Oncology Pipeline Database: 6-Month Subscription Product description Subscription to La Merie’s proprietary Oncology Pipeline Database provides online access to more than 3,000 project entries in oncology. Each project is specified for its Target or Mechanism of Action, Product Category and R&D Phase. Use of the R&D database of cancer drugs is intuitive. Data sets of interest...
$1544
 
Displaying 1 to 20 (of 20 records)
Pages: « Last  1